Legend Biotech Announces Preliminary Sales for CARVYKTI® for the[...]
Monro, Inc. to Report First Quarter Fiscal 2025 Earnings on July 31, 2024
07/16/2024 | Press release | Distributed by Public on 07/17/2024 05:28
Please select the service you want to use:
Smartlinks | 4D Molecular Therapeutics Inc. | News | Health | Science | Research | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Business Announcement | Products and Services | Financial Services | Pharmaceuticals | Real Estate | Securities Issuers | Biotechnology and Medical Research Companies | NYSE American | NYSE ARCA Equities | Nasdaq Global Market | Nasdaq Global Select Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact